The FTSE 100 firm said it still expects to earn between £550million and £570million in adjusted operating profits this year, ...

Findings from a phase 3 trial with Blenrep, Velcade and dexamethasone in relapsed/refractory multiple myeloma will be ...

Last Friday, Palantir (PLTR) announced the transfer of its Class A stock to the Nasdaq (QQQ) from the New York Stock Exchange ...

The sFlt-1/PlGF ratio did not effectively gauge future preeclampsia risk in pregnant patients with SLE and proteinuria.

TORONTO and PHILADELPHIA, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd (NASDAQ: MDCX TSXV: MDCX) (the “Company”) is pleased to announce the appointment of Faisal Mehmud, MD as Chief Medical ...

Durham non-profit among several to receive funding from GSK Denzel Washington rails against American politics: ‘You’re being ...

Durham Success Summit started five years ago and now many of the young men from the program have new careers outside Durham.

Markets are highly uncertain about the prospects for healthcare stocks. If the government is less supportive of vaccines, ...

Using cerebrospinal fluid from living patients, researchers have identified specific proteins and genetic pathways involved ...

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

Vaccine makers hit hardest as Robert F. Kennedy Jr. appointment to Department of Health raises concerns for US drug market.

FTSE 100 and 250 decline as AstraZeneca and GSK weigh down. UK economy contracts in surprise September downturn, impacting growth prospects.